Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
9.23
-0.18 (-1.91%)
At close: Aug 20, 2026, 4:00 PM EDT
9.24
+0.01 (0.11%)
After-hours: Aug 20, 2026, 4:53 PM EDT
Xilio Therapeutics Market Cap
Xilio Therapeutics has a market cap or net worth of $60.73 million as of August 20, 2026. Its market cap has increased by 71.90% in one year.
Market Cap
60.73M
Enterprise Value
-69.00M
1-Year Change
71.90%
Ranking
Category
Stock Price
$9.23
ChartMarket Cap Chart
Since the IPO on October 22, 2021, Xilio Therapeutics's market cap has decreased from $426.71M to $60.73M, a decrease of -85.77%. That is a compound annual growth rate of -33.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 60.73M | 80.70% |
| Dec 31, 2025 | 33.61M | -19.94% |
| Dec 31, 2024 | 41.98M | 177.26% |
| Dec 29, 2023 | 15.14M | -79.46% |
| Dec 30, 2022 | 73.73M | -83.14% |
| Dec 31, 2021 | 437.33M | 2.49% |
| Oct 22, 2021 | 426.71M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dogwood Therapeutics | 69.28M |
| Gossamer Bio | 68.44M |
| Pliant Therapeutics | 68.11M |
| PMV Pharmaceuticals | 66.66M |
| OS Therapies | 65.47M |
| MediciNova | 64.97M |
| Boundless Bio | 64.37M |
| ImageneBio | 63.34M |